載入...
Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: the Australian Trial in Acute Hepatitis C
BACKGROUND: A barrier to hepatitis C virus (HCV) treatment among people who inject drugs (PWID) has been a concern that interferon-based HCV treatment may increase injecting risk behaviours. This study evaluated recent (past month) injecting risk behaviours during follow-up among PWID that did and d...
Na minha lista:
| 發表在: | Int J Drug Policy |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4577441/ https://ncbi.nlm.nih.gov/pubmed/26115881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2015.05.003 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|